Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
34.04
-0.71 (-2.04%)
May 1, 2026, 4:00 PM EDT - Market closed
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $2.02 billion as of May 1, 2026. Its market cap has increased by 340.42% in one year.
Market Cap
2.02B
Enterprise Value
1.77B
1-Year Change
340.42%
Ranking
Category
Stock Price
$34.04
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $2.02B, an increase of 209.31%. That is a compound annual growth rate of 27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 2.07B | 47.32% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 2.20B |
| Mineralys Therapeutics | 2.19B |
| Definium Therapeutics | 2.18B |
| Adaptive Biotechnologies | 2.16B |
| Ascentage Pharma Group International | 2.10B |
| Stoke Therapeutics | 2.06B |
| Ocular Therapeutix | 2.03B |
| Zymeworks | 2.03B |